NPPA Fixes Retail Price of 15 Formulation, Detail Dr. Divya Colin10 May 2023 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceuticals Pricing Authority (NPPA) has fixed the retail of 15 scheduled formulations...
Dr Reddy's gets CDSCO panel nod to study Darbepoetin alfa Dr. Divya Colin1 March 2023 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India Farhat Nasim27 Jan 2023 6:26 PM ISTDelhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...
Health Ministry shocker in RTI reply: CDSCO, ICMR admit to multiple side effects of Covid-19 jabs Farhat Nasim17 Jan 2023 2:04 PM ISTNew Delhi: In a shocking response to an RTI query, the Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research...
Submit in vitro data and comparative data: CDSCO Tells Dr Reddy's on Icosapent Ethyl Capsule Dr. Divya Colin13 Dec 2022 6:00 PM ISTNew Delhi: Noting that the effect of Icosapentether on the risk of pancreatitis in patients with severe hypertriglyceridemia has yet to be determined,...
Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report Farhat Nasim22 Nov 2022 6:36 PM ISTNew Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...
Dr Reddy's Labs earmarks Rs 1,500 crore capex with focus on biosimilars, injectables Ruchika Sharma7 Nov 2022 2:30 PM ISTNew Delhi: Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities...
Dr. Reddy's gets CDSCO panel conditional nod to manufacture, market Nimesulide Granules Dr. Divya Colin20 Oct 2022 6:00 PM ISTNew Delhi: Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject...
LIC increases its stake in Dr Reddy's Laboratories from 5.65 percent to 7.7 percent Ruchika Sharma4 Oct 2022 11:01 AM ISTLIC's holding in the company stands at 7.7 percent, it added.
Dr Reddy's Labs, IQVIA ink pact for CRM solution for India field force Ruchika Sharma29 Sept 2022 11:15 AM ISTOCE is IQVIA's CRM Application Suite that enables life sciences clients to digitally transform their sales and marketing operations.
Meet 52 richest Indians in Pharma Healthcare domain Farhat Nasim21 Sept 2022 7:33 PM ISTNew Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
